Okamoto Industries, Inc.

5122.T
Specialty Chemicals
2026/08/21 Updated
Market Cap: $702.3M (¥111.7B)
Stock Price: $41.33 (¥6,570)
Exchange Rate: 1 USD = ¥158.98

Financial Summary for the Fiscal Year Ending March 2026 | Sales ¥108.4 billion (YoY +0.2%)

Okamoto's financial results for the fiscal year ending March 2026 show sales of ¥108.4 billion (YoY +0.2%) and net income of ¥4,860 million (YoY +4.4%), achieving profit growth. Business strategies and future outlook are also presented.

Importance:
Page Updated: May 14, 2026
IR Disclosure Date: May 14, 2026

Key Figures

  • Sales: ¥108.4 billion (YoY +0.2%)
  • Net Income: ¥4,860 million (YoY +4.4%)
  • Operating Income: ¥6,248 million (YoY +9.0%)

AI要約

Overview of Financial Performance

Okamoto's financial results for the fiscal year ending March 2026 show sales of ¥108.4 billion (YoY +0.2%), remaining flat overall, but with net income increasing by ¥4,860 million (YoY +4.4%). Operating income reached ¥6,248 million (up 9.0%), supported by recovery from the COVID-19 pandemic and expansion into new business areas. Segment-wise, strong sales of condom products and new market development contributed to revenue. Cost management and production efficiency improvements also enhanced profitability.

Future Outlook and Strategies

The company aims for sustainable growth through new product launches and expansion into overseas markets. Particular focus is placed on expanding into Asian markets and entering new health and hygiene sectors. Plans include enhancing digital marketing and e-commerce sales to strengthen competitiveness and brand value. In the medium to long term, the company will pursue environmental initiatives and sustainability efforts to enhance corporate value.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Okamoto Corporation

Company overview · Stock price · Financial data · All IR

View company page →